Mechanisms of podocyte injury and implications for diabetic nephropathy

被引:99
作者
Barutta, Federica [1 ]
Bellini, Stefania [1 ]
Gruden, Gabriella [1 ]
机构
[1] Univ Turin, Dept Med Sci, Turin, Italy
关键词
GLYCATION END-PRODUCTS; CANNABINOID RECEPTOR 1; SHARED TRANSCRIPTIONAL NETWORKS; NLRP3 INFLAMMASOME ACTIVATION; GLOMERULAR-FILTRATION-RATE; GLUCAGON-LIKE PEPTIDE-1; KIDNEY-DISEASE; MITOCHONDRIAL DYSFUNCTION; HIGH-GLUCOSE; NEPHROTIC SYNDROME;
D O I
10.1042/CS20210625
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and diabetic nephropathy (DN). Moreover, albuminuria is an important feature of all chronic kidney diseases (CKDs). Podocytes play a key role in maintaining the permselectivity of the glomerular filtration barrier (GFB) and injury of the podocyte, leading to foot process (FP) effacement and podocyte loss, the unifying underlying mechanism of proteinuric glomerulopathies. The metabolic insult of hyperglycemia is of paramount importance in the pathogenesis of DN, while insults leading to podocyte damage are poorly defined in other proteinuric glomerulopathies. However, shared mechanisms of podocyte damage have been identified. Herein, we will review the role of haemodynamic and oxidative stress, inflammation, lipotoxicity, endocannabinoid (EC) hypertone, and both mitochondrial and autophagic dysfunction in the pathogenesis of the podocyte damage, focussing particularly on their role in the pathogenesis of DN. Gaining a better insight into the mechanisms of podocyte injury may provide novel targets for treatment. Moreover, novel strategies for boosting podocyte repair may open the way to podocyte regenerative medicine. The kidneys filter approximately 180 l of fluids everyday; however, there is no loss of proteins into urine as the glomerular filtration barrier (GFB) retains 99.99% of plasma proteins. Alterations in the GFB result in the development of proteinuria, ranging from albuminuria to massive nephrotic syndrome. Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), diabetic nephropathy (DN), obesity-related nephropathy, and an important feature of chronic kidney diseases (CKDs). In addition, in patients with CKD, albuminuria is a predictor of progression towards end-stage renal disease (ESRD) and is associated with an increased risk of cardiovascular diseases. Glomerular podocytes are a component of the GFB and podocyte injury is the main cause of albuminuria development. Herein, we will describe patterns of podocyte damage and review underlying mechanisms, focussing particularly on DN.
引用
收藏
页码:493 / 520
页数:28
相关论文
共 337 条
[21]   Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy [J].
Barutta, Federica ;
Piscitelli, Fabiana ;
Pinach, Silvia ;
Bruno, Graziella ;
Gambino, Roberto ;
Rastaldi, Maria Pia ;
Salvidio, Gennaro ;
Di Marzo, Vincenzo ;
Perin, Paolo Cavallo ;
Gruden, Gabriella .
DIABETES, 2011, 60 (09) :2386-2396
[22]   Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy [J].
Barutta, Federica ;
Corbelli, Alessandro ;
Mastrocola, Raffaella ;
Gambino, Roberto ;
Di Marzo, Vincenzo ;
Pinach, Silvia ;
Rastaldi, Maria Pia ;
Perin, Paolo Cavallo ;
Gruden, Gabriella .
DIABETES, 2010, 59 (04) :1046-1054
[23]   Heat shock protein expression in diabetic nephropathy [J].
Barutta, Federica ;
Pinach, Silvia ;
Giunti, Sara ;
Vittone, Ferdinando ;
Forbes, Josephine M. ;
Chiarle, Roberto ;
Arnstein, Maryann ;
Perin, Paolo Cavallo ;
Camussi, Giovanni ;
Cooper, Mark E. ;
Gruden, Gabriella .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (06) :F1817-F1824
[24]   Mesenchymal Stromal Cell-Derived Extracellular Vesicles Pass through the Filtration Barrier and Protect Podocytes in a 3D Glomerular Model under Continuous Perfusion [J].
Bellucci, Linda ;
Montini, Giovanni ;
Collino, Federica ;
Bussolati, Benedetta .
TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2021, 18 (04) :549-560
[25]   Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome [J].
Beltcheva, O ;
Martin, P ;
Lenkkeri, U ;
Tryggvason, K .
HUMAN MUTATION, 2001, 17 (05) :368-373
[26]   Inhibiting Angiotensin-Converting Enzyme Promotes Renal Repair by Limiting Progenitor Cell Proliferation and Restoring the Glomerular Architecture [J].
Benigni, Ariela ;
Morigi, Marina ;
Rizzo, Paola ;
Gagliardini, Elena ;
Rota, Cinzia ;
Abbate, Mauro ;
Ghezzi, Serena ;
Remuzzi, Andrea ;
Remuzzi, Giuseppe .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (02) :628-638
[27]   Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy [J].
Berthier, Celine C. ;
Zhang, Hongyru ;
Schin, MaryLee ;
Henger, Anna ;
Nelson, Robert G. ;
Yee, Berne ;
Boucherot, Anissa ;
Neusser, Matthias A. ;
Cohen, Clemens D. ;
Carter-Su, Christin ;
Argetsinger, Lawrence S. ;
Rastaldi, Maria P. ;
Brosius, Frank C. ;
Kretzler, Matthias .
DIABETES, 2009, 58 (02) :469-477
[28]   Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis [J].
Birk, A. V. ;
Chao, W. M. ;
Bracken, C. ;
Warren, J. D. ;
Szeto, H. H. .
BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (08) :2017-2028
[29]   GLOMERULAR EPITHELIAL FOOT PROCESSES AND FILTRATION SLITS IN IDDM PATIENTS [J].
BJORN, SF ;
BANGSTAD, HJ ;
HANSSEN, KF ;
NYBERG, G ;
WALKER, JD ;
VIBERTI, GC ;
OSTERBY, R .
DIABETOLOGIA, 1995, 38 (10) :1197-1204
[30]   Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury [J].
Blattner, Simone M. ;
Hodgin, Jeffrey B. ;
Nishio, Masashi ;
Wylie, Stephanie A. ;
Saha, Jharna ;
Soofi, Abdul A. ;
Vining, Courtenay ;
Randolph, Ann ;
Herbach, Nadja ;
Wanke, Ruediger ;
Atkins, Kevin B. ;
Kang, Hee Gyung ;
Henger, Anna ;
Brakebusch, Cord ;
Holzman, Lawrence B. ;
Kretzler, Matthias .
KIDNEY INTERNATIONAL, 2013, 84 (05) :920-930